Genprex Inc (GNPX)
2.32
-0.11
(-4.53%)
USD |
NASDAQ |
May 10, 16:00
2.38
+0.06
(+2.59%)
After-Hours: 20:00
Genprex Shareholders Equity (Quarterly): 7.416M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.416M |
September 30, 2023 | 12.31M |
June 30, 2023 | 12.05M |
March 31, 2023 | 18.48M |
December 31, 2022 | 22.27M |
September 30, 2022 | 27.49M |
June 30, 2022 | 32.41M |
March 31, 2022 | 37.02M |
December 31, 2021 | 41.28M |
September 30, 2021 | 45.17M |
June 30, 2021 | 47.68M |
March 31, 2021 | 50.42M |
December 31, 2020 | 30.92M |
September 30, 2020 | 22.98M |
June 30, 2020 | 24.51M |
Date | Value |
---|---|
March 31, 2020 | 23.94M |
December 31, 2019 | 3.024M |
September 30, 2019 | 3.531M |
June 30, 2019 | 5.325M |
March 31, 2019 | 7.245M |
December 31, 2018 | 8.881M |
September 30, 2018 | 10.48M |
June 30, 2018 | 12.59M |
March 31, 2018 | -0.0419M |
December 31, 2017 | 0.4286M |
September 30, 2017 | 0.8715M |
June 30, 2017 | 0.7981M |
March 31, 2017 | 1.107M |
December 31, 2016 | 1.625M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.024M
Minimum
Dec 2019
50.42M
Maximum
Mar 2021
24.64M
Average
23.94M
Median
Mar 2020
Shareholders Equity (Quarterly) Benchmarks
Lifecore Biomedical Inc | -1.842M |
Jaguar Health Inc | 4.961M |
Aquestive Therapeutics Inc | -36.30M |
TFF Pharmaceuticals Inc | 9.567M |
Calidi Biotherapeutics Inc | -8.235M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 10.67M |
Total Liabilities (Quarterly) | 3.254M |